Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

The common food additive carrageenan is not a ligand for Toll-Like- Receptor 4 (TLR4) in an HEK293-TLR4 reporter cell-line model.

McKim JM Jr, Wilga PC, Pregenzer JF, Blakemore WR.

Food Chem Toxicol. 2015 Apr;78:153-8. doi: 10.1016/j.fct.2015.01.003. Epub 2015 Jan 29.

2.

Microarray analysis in human hepatocytes suggests a mechanism for hepatotoxicity induced by trovafloxacin.

Liguori MJ, Anderson MG, Bukofzer S, McKim J, Pregenzer JF, Retief J, Spear BB, Waring JF.

Hepatology. 2005 Jan;41(1):177-86.

PMID:
15619227
4.
5.

Agonist-induced GTPgamma35S binding mediated by human 5-HT(2C) receptors expressed in human embryonic kidney 293 cells.

Alberts GL, Pregenzer JF, Im WB, Zaworski PG, Gill GS.

Eur J Pharmacol. 1999 Nov 3;383(3):311-9.

PMID:
10594325
6.

Efficient functional coupling of the human D3 dopamine receptor to G(o) subtype of G proteins in SH-SY5Y cells.

Zaworski PG, Alberts GL, Pregenzer JF, Im WB, Slightom JL, Gill GS.

Br J Pharmacol. 1999 Nov;128(6):1181-8.

7.

Differential pharmacology between the guinea-pig and the gorilla 5-HT1D receptor as probed with isochromans (5-HT1D-selective ligands).

Pregenzer JF, Alberts GL, Im WB, Slightom JL, Ennis MD, Hoffman RL, Ghazal NB, TenBrink RE.

Br J Pharmacol. 1999 May;127(2):468-72.

8.
10.

Isochroman-6-carboxamides as highly selective 5-HT1D agonists: potential new treatment for migraine without cardiovascular side effects.

Ennis MD, Ghazal NB, Hoffman RL, Smith MW, Schlachter SK, Lawson CF, Im WB, Pregenzer JF, Svensson KA, Lewis RA, Hall ED, Sutter DM, Harris LT, McCall RB.

J Med Chem. 1998 Jun 18;41(13):2180-3. No abstract available.

PMID:
9632349
11.

Two imidazoquinoxaline ligands for the benzodiazepine site sharing a second low affinity site on rat GABA(A) receptors but with the opposite functionality.

Im HK, Im WB, Pregenzer JF, Stratman NC, VonVoigtlander PF, Jacobsen EJ.

Br J Pharmacol. 1998 Apr;123(8):1490-4.

13.
15.

U-89843A is a novel allosteric modulator of gamma-aminobutyric acidA receptors.

Im HK, Im WB, Pregenzer JF, Carter DB, Hamilton BJ.

J Pharmacol Exp Ther. 1995 Dec;275(3):1390-5.

PMID:
8531107
16.
17.

Characterization of U-97775 as a GABAA receptor ligand of dual functionality in cloned rat GABAA receptor subtypes.

Im HK, Im WB, Pregenzer JF, Carter DB, Jacobsen EJ, Hamilton BJ.

Br J Pharmacol. 1995 May;115(1):19-24.

18.

Acceleration of GABA-dependent desensitization by mutating threonine 266 to alanine of the alpha 6 subunit of rat GABAA receptors.

Im WB, Binder JA, Dillon GH, Pregenzer JF, Im HK, Altman RA.

Neurosci Lett. 1995 Feb 17;186(2-3):203-7.

PMID:
7777197
19.
20.
21.

Differential affinity of dihydroimidazoquinoxalines and diimidazoquinazolines to the alpha 1 beta 2 gamma 2 and alpha 6 beta 2 gamma 2 subtypes of cloned GABAA receptors.

Im WB, Im HK, Pregenzer JF, Hamilton BJ, Carter DB, Jacobsen EJ, TenBrink RE, VonVoigtlander PF.

Br J Pharmacol. 1993 Oct;110(2):677-80.

22.

Substituted pyrazinones, a new class of allosteric modulators for gamma-aminobutyric acidA receptors.

Im HK, Im WB, Judge TM, Gammill RB, Hamilton BJ, Carter DB, Pregenzer JF.

Mol Pharmacol. 1993 Aug;44(2):468-72.

PMID:
8018215
25.

Differential potentiation of GABAA receptor function by two stereoisomers of diimidazoquinazoline analogues.

Im HK, Im WB, Pregenzer JF, Petke JD, Hamilton BJ, Carter DB, Von Voigtlander PF, Hansen HC, Kristiansen M.

Br J Pharmacol. 1992 Oct;107(2):622-7.

26.

Characterization of functional interactions of imidazoquinoxaline derivatives with benzodiazepine-gamma-aminobutyric acidA receptors.

Petke JD, Im HK, Im WB, Blakeman DP, Pregenzer JF, Jacobsen EJ, Hamilton BJ, Carter DB.

Mol Pharmacol. 1992 Aug;42(2):294-301.

PMID:
1355261
27.

Induction of cobalt accumulation by excitatory amino acids within neurons of the hippocampal slice.

Williams LR, Pregenzer JF, Oostveen JA.

Brain Res. 1992 May 29;581(2):181-9.

PMID:
1382799
28.

The 21-aminosteroid inhibitors of lipid peroxidation: reactions with lipid peroxyl and phenoxy radicals.

Braughler JM, Pregenzer JF.

Free Radic Biol Med. 1989;7(2):125-30.

PMID:
2806938
29.

Novel membrane localized iron chelators as inhibitors of iron-dependent lipid peroxidation.

Braughler JM, Burton PS, Chase RL, Pregenzer JF, Jacobsen EJ, VanDoornik FJ, Tustin JM, Ayer DE, Bundy GL.

Biochem Pharmacol. 1988 Oct 15;37(20):3853-60.

PMID:
3190732
30.

Stimulation and inhibition of iron-dependent lipid peroxidation by desferrioxamine.

Braughler JM, Chase RL, Pregenzer JF.

Biochem Biophys Res Commun. 1988 Jun 30;153(3):933-8.

PMID:
3390189
31.

Oxidation of ferrous iron during peroxidation of lipid substrates.

Braughler JM, Chase RL, Pregenzer JF.

Biochim Biophys Acta. 1987 Oct 17;921(3):457-64.

PMID:
3117117
32.

Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation.

Braughler JM, Pregenzer JF, Chase RL, Duncan LA, Jacobsen EJ, McCall JM.

J Biol Chem. 1987 Aug 5;262(22):10438-40.

Supplemental Content

Loading ...
Support Center